Haleon plc (NYSE:HLN) Declares — Dividend of $0.12

Haleon plc (NYSE:HLN) announced a — dividend on Monday, March 3rd, Wall Street Journal reports. Investors of record on Friday, April 25th will be paid a dividend of 0.1166 per share on Thursday, June 5th. This represents a yield of 1.6%. The ex-dividend date of this dividend is Friday, April 25th. This is a boost from Haleon’s previous — dividend of $0.05.

Haleon has a payout ratio of 43.4% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Haleon to earn $0.49 per share next year, which means the company should continue to be able to cover its $0.23 annual dividend with an expected future payout ratio of 46.9%.

Haleon Trading Up 4.0 %

Shares of HLN opened at $10.59 on Tuesday. The firm’s 50 day simple moving average is $9.59 and its 200 day simple moving average is $9.84. The company has a market capitalization of $47.94 billion, a P/E ratio of 31.15, a P/E/G ratio of 2.82 and a beta of 0.28. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. Haleon has a 1-year low of $7.89 and a 1-year high of $10.81.

Haleon (NYSE:HLN) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.05 EPS for the quarter. The firm had revenue of $3.54 billion for the quarter, compared to the consensus estimate of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. Sell-side analysts forecast that Haleon will post 0.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have commented on HLN shares. Morgan Stanley downgraded shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Sanford C. Bernstein downgraded shares of Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $10.95.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.